Sentences with phrase «of kidney dialysis»

Furthermore, paired kidney transplants using organs from deceased or live donors, makes compelling sense from a cost perspective, compared to the alternative of the pain and discomfort of kidney dialysis treatment.
The decade witnessed the advent of kidney dialysis, organ transplantation, the birth - control pill, intensive - care units, the artificial respirator, prenatal diagnosis and the first glimmering of the genetic revolution.
UnitedHealth struck a $ 4.9 billion deal on Wednesday to acquire the DaVita Medical Group unit of kidney dialysis firm DaVita in an all - cash transaction.
UnitedHealth has struck a $ 4.9 billion deal to acquire the DaVita Medical unit of kidney dialysis firm DaVita in an all - cash transaction.

Not exact matches

Dean Kamen, inventor of the world's first portable kidney dialysis machine, the world's first portable drug - infusion pump, the Segway and the Slingshot machine that can turn anything wet into clean drinking water exhibits this belief, too.
While mindful of the negative connotations that might arise from manufacturing body parts and implanting them, cyborg style, in humans, he doubts someone on a waiting list for a new kidney and requiring daily dialysis would have such qualms.
FMC had bought Sound Inpatient to build up a so - called care coordination business to expand into other types of therapy that kidney dialysis patients typically need.
The Division of Pediatric Nephrology at Floating Hospital for Children in Boston offers a range of services for kids with kidney disease, including renal biopsies, acute and chronic dialysis, 24 - hour blood pressure monitoring, hemofiltration and renal transplantation.
I am on kidney dialysis and am only allowed certain kinds of cereal.
Twenty patients with kidney failure, for example, showed levels of ammonia and acetone more than 10 times that of healthy controls, and the researchers could watch those levels fall back to normal as the patients received dialysis treatment.
In medicine, renal dialysis is a method for removing waste such as urea from the blood when the kidneys are incapable of this (i.e. in renal failure).
«Patients on dialysis are living longer and equally positive, survival rates have steadily improved among recipients of both living and deceased donor kidney transplants.»
The past century's great advances in medical diagnosis and treatment — including kidney dialysis, artificial body parts such as lenses and joints, magnetic resonance imaging, and genetic testing — could have happened only with crucial contributions from physical scientists and engineers, who will also be needed for the next generation of health care miracles.
Patients with diabetes and suffering from acute kidney injury (AKI), proteinuria and uncontrolled blood sugar experience a sharp reduction in the number of years they have healthy renal function before being forced onto dialysis, according to researchers at the University of Cincinnati (UC) College of Medicine.
Image courtesy of iStockphoto / adventtr More than 382,000 people with kidney disease in the U.S. are on dialysis, a painful procedure that can wreak havoc on blood vessels due to constant jabs from large needles.
«The majority of patients with chronic kidney disease, particularly those in the more advanced stages who require dialysis, exhibited some degree of loss of their sense of smell, which correlated with reduced nutritional status,» says Teodor Paunescu, PhD, of the MGH Division of Nephrology, corresponding author of the study.
In patients with chronic kidney disease who are not on dialysis, ACEIs and ARBs slow the progression of diabetic nephropathy and reduce cardiovascular risk.
First author Sagar Nigwekar, MD, also of MGH Nephrology, explains, «More than 25 million adults in the U.S. have chronic kidney disease, with more than half a million requiring dialysis.
In the current study, McAllister's team implanted them into 10 kidney dialysis patients in Argentina and Poland, all of whom had suffered previous graft failures.
The current study enrolled 161 participants — 100 with end - stage kidney disease, all of whom were dialysis dependent; 36 with chronic disease not yet at the end stage, and 25 healthy controls.
In 2015, 87,538 patients with end - stage renal disease died while on dialysis (16.3 percent of all dialysis patients are awaiting kidney transplants), and 18,805 kidney transplantations were performed that same year.
The answers, I learned, lay in the grinding poverty and entrenched corruption of India, the desperation of patients on dialysis, and the transnational nature of the black market transplant business — which, though dominated by the kidney exchange, includes livers and hearts as well.
That paper reported that two - thirds of Type 2 diabetic men with chronic kidney disease have low testosterone levels and that among patients on dialysis, a remarkable 90 percent have low testosterone.
Nearly 17 percent of people in the U.S. have chronic kidney disease, and approximately 4 percent require dialysis and / or a kidney transplant due to kidney failure.
Prior evidence suggested that the variants may play a role in chronic kidney disease in blacks, however, the association of these hemoglobin traits to progression to kidney failure requiring dialysis was unknown.
Intensive dialysis treatments in pregnant women with kidney failure lead to a higher proportion of live births than standard dialysis care, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Yet, a new study conducted by Mayo Clinic and the University of Michigan shows that only one - third of patients who ultimately receive a living donor kidney transplant receive it pre-emptively (i.e., before starting dialysis).
With few treatments currently available, symptoms include high blood pressure and loss of kidney function, and lead to the need for dialysis.
«Enlarged cysts in kidneys can lead to reduced kidney function and eventually kidney failure, where the only treatment is dialysis or transplantation,» said study author Michael Flessner, M.D., Ph.D., a program director at the NIH's National Institute of Diabetes and Digestive and Kidney Diseases, which funded the kidney function and eventually kidney failure, where the only treatment is dialysis or transplantation,» said study author Michael Flessner, M.D., Ph.D., a program director at the NIH's National Institute of Diabetes and Digestive and Kidney Diseases, which funded the kidney failure, where the only treatment is dialysis or transplantation,» said study author Michael Flessner, M.D., Ph.D., a program director at the NIH's National Institute of Diabetes and Digestive and Kidney Diseases, which funded the Kidney Diseases, which funded the trial.
For example, the authors suggest that hepatitis C - positive kidneys should be offered to uninfected patients who have a high risk of health deterioration if they continue dialysis — including elderly patients or those with serious co-existing conditions, such as cardiovascular disease — disadvantageous blood types or other conditions that would mean many years of waiting for an appropriate hepatitis C - negative kidney to become available.
Investigators led by Suma Prakash, MD, FRCPC, MSc (Case Western Reserve University) wondered whether a model called the «behavioral stage of change» model, which was originally used to help people quit smoking, might help patients with chronic kidney disease take action and make decisions about their dialysis options.
The authors also acknowledge that although the costs of transplanting hepatitis C - infected kidneys into uninfected recipients would be high, they may be offset by savings from reduced dialysis time for recipients who would otherwise wait longer for a kidney.
This response prevents patients from having a successful kidney transplant and they often remain on dialysis for years with diminished quality and length of life.
Approximately half of individuals with autosomal dominant polycystic kidney disease eventually will require dialysis or kidney transplant by age 60.
«If maintained long - term, this could reduce risk of progression to end - stage kidney disease — where dialysis or transplant is required to survive — by 30 %.»
These individuals have a very high risk of cardiovascular disease, and some will also progress to kidney failure requiring dialysis and transplantation.
PATIENTS who undergo kidney dialysis at some French clinics risk contracting hepatitis C from contaminated dialysis machines, warns a report from the Inspector General of Social Affairs.
Autosomal dominant polycystic kidney disease, which is the fourth most common cause of end - stage kidney disease, requires dialysis or kidney transplant.
«This letter highlights the use of a novel regimen and may give the patients with a kidney transplant and cancer hope of treating the cancer while keeping the kidney and thereby avoiding dialysis
Although 17,000 people receive kidneys in the US each year, more than 400,000 are on the waiting list and rely on dialysis machines, so the shortage of available organs remains acute.
Research has shown that kidney transplantation results in longer survival, better quality of life, and long - term cost savings compared with dialysis for patient with kidney failure.
Unfortunately, these conditions are the main cause of end - stage kidney disease and the need for dialysis in children.
Already, researchers at Vanderbilt University and the University of California, San Francisco, are collaborating on the construction of an implantable bio-artificial kidney that would contain microscopic filters and living kidney cells in a coffee - cup - size device that would work like a living dialysis machine inside the body — and provide most of the benefits of a kidney transplant.
ARANESP ® is used to treat anemia, a deficiency in the number of red blood cells, caused by chronic kidney failure in patients both on dialysis and not on dialysis.
It is the leading cause of end - stage renal failure in the United States and the only existing treatment options are dialysis and kidney transplantation.
Petrelli A, Tresoldi E, Mfarrej BG, Paganelli A, Spotti D, Caldara R, Secchi A, Battaglia M. Generation of donor - specific T regulatory type 1 (Tr1) cells from patients on dialysis for cell therapy after kidney transplantation.
Feb. 12, 2016 — Vanderbilt University Medical Center nephrologist and Associate Professor of Medicine Dr. William Fissell IV is making major progress on a first - of - its kind device to free kidney patients from dialysis.
About a half million people in the US — 44 percent of whom are diabetics — have ESRD, which requires dialysis or kidney transplantation.
Researchers at Whitehead Institute have identified a key target protein of glucocorticoids, the drugs that are used to increase red blood cell production in patients with certain types of anemia, including those resulting from trauma, sepsis, malaria, kidney dialysis, and chemotherapy.
As a person with kidney disease having to take dialysis three days a week, she cleaned people's houses in the «nice neighborhoods» part - time while taking care of my siblings and I full - time, making sure we always had a full breakfast, a packed lunch for school, a snack waiting for us when we returned home and dinner before off to bed.
a b c d e f g h i j k l m n o p q r s t u v w x y z